RaiseTrack

Arboretum LifeSciences Series A (2026)

Arboretum LifeSciences launched with a $30 million Series A, announced on 2026-10-06, led by F-Prime, GV, .406 Ventures, Hims & Hers and Amgen.

Company
Arboretum LifeSciences
Round type
Series A
Date
2026-10-06
Amount
$30M
Industry
molecular information, genetic testing, precision medicine
Location
Cambridge, MA

Summary

Arboretum LifeSciences launched on 2026-10-06 with a $30 million Series A. The company announcement says the round was led by F-Prime, GV, .406 Ventures, Hims & Hers, Amgen and other industry leaders, so all five are shown as leads. FinSMEs lists the same five as backers without naming a lead. The company plans to use the funds to build scientific and operational infrastructure and to scale its research network.

Investors

Lead

Sources

Last verified:

  1. https://www.arboretum.bio/news/arboretum-launch
    Type: company announcement. Accessed 2026-10-08.
    Arboretum launch announcement, datelined Cambridge, Mass. Says the company launched with a $30 million Series A led by F-Prime, GV, .406 Ventures, Hims & Hers, Amgen and other industry leaders, and names partners Advocate Health, Geisinger, Providence Healthcare and Cardiovascular Associates of America.
  2. https://bostonlifesciencestimes.com/2026/10/arboretum-launches-with-30-million-to-expand-precision-medicine-for-common-diseases/
    Type: reputable publication. Accessed 2026-10-08.
    Boston Life Sciences Times article dated 2026-10-06. Confirms the Cambridge location, the $30 million Series A led by F-Prime, GV, .406 Ventures, Hims & Hers and Amgen, and the four healthcare partners.
  3. https://allsci.com/news/biotech/genomic-medicine-arboretum-lifesciences-launches/
    Type: reputable publication. Accessed 2026-10-08.
    AllSci article dated 2026-10-07. Confirms the amount, stage and the five lead investors, and says co-founder and CEO Anthony Philippakis is also a general partner at GV.
  4. https://www.finsmes.com/2026/10/arboretum-lifesciences-raises-30m-in-series-a-funding.html
    Type: reputable publication. Accessed 2026-10-08.
    FinSMEs article dated 2026-10-07. Confirms the Cambridge, MA location and the $30 million Series A, and lists F-Prime, GV, .406 Ventures, Hims & Hers and Amgen as backers without naming a lead.